Pdp (68071 2820 6)
Pregabalin
Product Images NDC 68071-2820
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 68071-2820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Pregabalin Fig01)
Figure 2 (Pregabalin Fig02)
Figure 3 (Pregabalin Fig03)
Figure 4 (Pregabalin Fig04)
Figure 5 (Pregabalin Fig05)
Figure 6 (Pregabalin Fig06)
Figure 7 (Pregabalin Fig07)
Figure 9 (Pregabalin Fig08)
Figure 10 (Pregabalin Fig09)
Figure 11 (Pregabalin Fig10)
The text does not provide enough information to generate a useful description.*
Figure 12 (Pregabalin Fig11)
This text appears to be presenting data on the percentage of subjects who improved during a study. The numbers 100, 210, 220, 230, 240, 250, 260, 270, 280, and 200 indicate the percentage of subjects who improved at different points in the study. The terms "BOCF," "Pregabalin," and "Placebo" suggest that the study may be focused on comparing the effectiveness of different treatments. However, without further information, it is difficult to provide a more specific description.*
Cockcroft And Gault Equation (Pregabalin Formula)
This text appears to describe a formula to calculate CLCT (possibly related to clearance) using age, weight, and serum creatinine. However, due to errors in and missing information, a complete and accurate description is not available.*
Chemical Structure (Pregabalin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
